Next Article in Journal
Sustained Crohn’s Disease Remission with an Exclusive Elemental and Exclusion Diet: A Case Report
Previous Article in Journal
Climate Change and Enteric Infections in the Canadian Arctic: Do We Know What’s on the Horizon?
Correction

Correction: Farrukh, A.; Mayberry, J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. Gastrointest. Disord. 2020, 2, 144–151

Department of Digestive Diseases, University Hospitals of Leicester NHS Trust, Leicester LE5 4PW, UK
*
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2021, 3(3), 127-128; https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3030013
Received: 26 July 2021 / Accepted: 27 July 2021 / Published: 10 August 2021
The authors wish to make the following correction to this paper [1]:
In the original article, there was a mistake in Table 1, as published. For Croydon Health Services NHS Trust, the Cases of IBD in White Irish should be 46; the Cases of IBD in White Other should be 20; the Expected cases of IBD in White Irish should be 63; and the Expected cases of IBD in White Other should be 168.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Farrukh, A.; Mayberry, J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. Gastrointest. Disord. 2020, 2, 144–151. [Google Scholar] [CrossRef]
Table 1. Hospital admission statistics and biologic use in the management of inflammatory bowel disease between 2014–2018 in selected NHS trusts with significant Black and Ethnic Minority (BEM) populations in England.
Table 1. Hospital admission statistics and biologic use in the management of inflammatory bowel disease between 2014–2018 in selected NHS trusts with significant Black and Ethnic Minority (BEM) populations in England.
White BritishWhite IrishWhite OtherWhiteAfro-CaribbeanAsian
Wye Valley NHS Trust
In-Patient Admissions
Population172,0007507200
Cases of IBD336824112
Expected Cases of IBD336815141
Proportion Statistic 1.46−1.8
Significance n.s.n.s.
University Hospitals of Bristol NHS Foundation Trust
Use of Biologics
Population334,000390022,000360,00019,000
Cases of IBD429516450<5
Expected Cases of IBD42952845024
Proportion Statistic 1.8 −3.78
Significance n.s.n.s. p < 0.002
Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
Use of Biologics
Population136,0004443700
Cases of IBD16538
Expected Cases of IBD16515
Proportion Statistic −1−0.8
Significance n.s.n.s.
Croydon Health Services NHS Trust
In-Patient Admissions
Population172,00054002300180,00060,500
Cases of IBD147546201706230
Expected Cases of IBD147563168 573
Proportion Statistic −1.611 −61.4
Significance n.s.p < 0.0001 p < 0.00001
Nottingham University Hospitals NHS Trust
In-Patient Admissions
Population 276,00014,100
Cases of IBD 513352
Expected Cases of IBD 5133262
Proportion Statistic 9.4
Significance p < 0.00001
University Hospitals of Derby and Burton NHS Foundation Trust
In-Patient Admissions
Population 377,0007500
Cases of IBD 16,11169
Expected Cases of IBD 16,111321
Proportion Statistic −12.9
Significance p < 0.00001
University Hospitals of Birmingham NHS Foundation Trust
Use of Biologics
Population 622,00078,000
Cases of IBD 946
Expected Cases of IBD 9412
Proportion Statistic −1.4
Significance n.s.
Kings College Hospital NHS Foundation Trust
In-Patient Admissions:
Population 170,00078,500
Cases of IBD 13,0032257
Expected Cases of IBD 13,0036004
Proportion Statistic −42.3
Significance p < 0.00001
NorthWest Anglia NHS Foundation Trust
In-Patient Admissions
Population159,000150022,000 18,000
Cases of IBD816139305 236
Expected Cases of IBD8161771129 924
Proportion Statistic −3.6−22.1 −20.5
Significance p < 0.0003p < 0.00001 p < 0.00001
The Princess Alexandra Hospital NHS Trust
In-Patient Admissions
Population71,0008002900 28002100
Cases of IBD371027118 837
Expected Cases of IBD371042152 146110
Proportion Statistic −1.8−2.1 −11.3−6.1
Significance n.s.p < 0.03 p < 0.00001p <0.00001
n.s. = not significant, IBD = Inflammatory Bowel Disease.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Back to TopTop